摘要
TRPV1(transient receptor potential vanilloid-1)是配体门控的非选择性阳离子通道,属于瞬时受体电位通道家族,能够被多种物理和化学刺激激活。TRPV1是药物研发的重要靶点之一,其异常刺激和表达与多种疾病的发病机制有关。一直以来,TRPV1因其调节剂优异的镇痛效果而备受关注。2021年诺贝尔生理学奖对温度和触觉感受器研究工作的认可,使TRPV1再一次成为关注的焦点。TRPV1已有20多年的研究基础,但是其门控机制和药物研发仍然是研究的难点。本文从TRPV1的生理功能、门控机制和药物发现的角度出发,综述了TRPV1的表达分布、功能特点和结构特征,重点阐述了3种门控机制及TRPV1调节剂在药物发现上的进展,并对未来的TRPV1药物进行展望。
Transient receptor potential vanilloid 1(TRPV1)channel,belonging to transient receptor potential(TRP)channel superfamily,is a ligand gated non-selective cation channel which can be activated by multiple physical and chemical stimuli.The abnormal irritation and expression of TRPV1 is involved in pathogenesis of various diseases,so that TRPV1 channel is one of the important targets for drug research and development.For a long time,TRPV1 channel has attracted much attention because of the excellent analgesic effect of TRPV1modulators.Due to the recognition of the research work of receptors for temperature and touch by the 2021 Nobel Prize in physiology or medicine,TRPV1 channel has become the focus of attention once again.It has been more than 20 years of the research for TRPV1,but the gating mechanism and drug development are still the difficulties.TRPV1 agonists can only be used for topical administration,and the antagonists could be used for oral administration.However,the problem with antagonists is that they cause hyperthermia and damage to noxious heat detection,which is the result of TRPV1 antagonists simultaneously affecting capsaicin,H+and heat gating.Studies have shown that there are common processes of the three gating mechanisms,but no way to affect a single gating mechanism.From the angles of physiological function,gating mechanism and drug discovery,this paper reviews the distribution and expression,functions and features as well as structural characteristics of TRPV1channel.This paper focuses on three gating mechanisms and the progress of TRPV1 modulators in drug discovery.TRPV1 modulators are a exceptional analgesia drug,and have been studied in cardiovascular diseases,itch,cough,psychiatric disorders and diabetes.With the emerging of artificial intelligence(AI)-assisted drug design and the continuous exploration of gating mechanism,we should have confidence in the future of TRPV1 modulators.
作者
魏鑫淼
杨启帆
田家豪
杨行
潘里
丁俊杰
WEI Xin-Miao;YANG Qi-Fan;TIAN Jia-Hao;YANG Hang;PAN Li;DING Jun-Jie(State Key Laboratory of NBC Protection for Civilian,Beijing 102205,China;School of Physics and Electronic Engineering,Sichuan University of Science&Engineering,Zigong 643000,China)
出处
《生物化学与生物物理进展》
SCIE
CAS
CSCD
北大核心
2023年第3期421-436,共16页
Progress In Biochemistry and Biophysics